Graphite Bio's first drug program will target sickle cell anaemia based on innovations in DNA editing from Stanford University.

Dell's stake in the software release technology provider is sized at almost $490m following an initial public offering in which it floated well above its range.

The data services software provider had raised more than $55m from investors including NetApp, Cisco Investments, Hewlett Packard Enterprise and GE Ventures.

Lilly Asia Ventures achieved an exit as the gastrointestinal and liver disease drug developer priced its initial public offering in the middle of its range.

The customer support technology provider lifted its overall funding to $88m in a Next47 Ventures-backed round that will support research and development.

Giant Eagle-backed warehouse vehicle manufacturer Seegrid has more than doubled its latest round to $52m, building on an initial $25m from G2VP six months ago.

Merck Global Health Innovation Fund contributed to a series B round that boosted the drone-based delivery service's total funding to $75m.

College benchmarking system ABC Insights measures, categorises and compares human capital spend at its member institutions on administrative functions such as IT management and communications.

Salesforce Ventures will invest another $250m as the data management software provider floated above its range at a valuation just short of $29bn.

Lennar, SoftBank, Access Industries and Alphabet are set to score exits from the real estate transaction manager, valued at $4.8bn in the deal.